Abstract
IntroductionPsoriatic arthritis (PsA) affects around 150 000 people in the UK of whom around 50% require treatment with biologics. The most used biologics for PsA target tumour necrosis factor (TNF)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have